Difelikefalin 1 mg Oral Tablet

DRUG2 trials

Sponsors

Cara Therapeutics, Inc.

Conditions

Chronic Kidney DiseasesPruritus

Phase 3

A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

TerminatedNCT05342623

Cara Therapeutics, Inc.Chronic Kidney Diseases, Pruritus

Start: 2022-05-17End: 2024-02-29Updated: 2024-05-07

CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

TerminatedNCT05356403

Cara Therapeutics, Inc.Chronic Kidney Diseases, Pruritus

Start: 2022-08-26End: 2024-02-26Updated: 2024-05-07